CL vs CVS · P/E 34, rev $20.38B vs P/E 16, rev $402.07B
Colgate-Palmolive Company (CL) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CL currently screens at market cap $70.88B and trailing P/E 34.3. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CL and CVS stock pages for the full models.
Not investment advice.